CHAPTER 1 INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2 RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3 MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4 MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Growing prevalence of cancer, brain tumours, & neurological diseases
4.1.2. Increasing preference towards minimally-invasive procedures
4.1.3. The high success rate of gamma knife procedures
4.1.4. Increasing adoption of gamma knife instruments in surgical centers
4.1.5. Growing government initiatives & advanced features of gamma knife systems
4.2. Market Restraints & Challenges
4.2.1. Strict regulatory requirements and lengthy approval time
4.2.2. The high cost of implementation
4.2.3. Lack of skilled manpower
4.3. Market Opportunities
4.3.1. Technological upgradation and advancements
CHAPTER 5 GLOBAL GAMMA KNIFE MARKET – BY INDICATION
5.1. Brain Metastasis
5.2. Arteriovenous Malformation
5.3. Cancer
5.4. Trigeminal Neuralgia
5.5. Movement Disorders
5.6. Malignant Tumors
5.7. Vascular Disorders
5.8. Ocular Disorders
5.9. Brain Tumors
5.10. Functional Disorders
5.11. Others
CHAPTER 6 GLOBAL GAMMA KNIFE MARKET – BY ANATOMY
6.1. Head
6.2. Neck
6.3. Others
CHAPTER 7 GLOBAL GAMMA KNIFE MARKET – BY END USER
7.1. Hospitals
7.2. Clinics
7.3. Ambulatory Centers
CHAPTER 8 GLOBAL GAMMA KNIFE MARKET - BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.2.4. Costa Rica
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Chile
8.3.4. Columbia
8.3.5. Others
8.4. Europe
8.4.1. U.K.
8.4.2. Germany
8.4.3. France
8.4.4. Italy
8.4.5. Spain
8.4.6. Russia
8.4.7. Netherlands
8.4.8. Switzerland
8.4.9. Poland
8.4.10. Others
8.5. APAC
8.5.1. China
8.5.2. Japan
8.5.3. India
8.5.4. South Korea
8.5.5. Australia & New Zealand
8.5.6. Malaysia
8.5.7. Singapore
8.5.8. Others
8.6. Middle East & Africa
8.6.1. UAE
8.6.2. Saudi Arabia
8.6.3. Iran
8.6.4. Iraq
8.6.5. Qatar
8.6.6. South Africa
8.6.7. Algeria
8.6.8. Morocco
8.6.9. Nigeria
8.6.10. Egypt
8.6.11. Others
CHAPTER 9 GLOBAL GAMMA KNIFE MARKET - COMPANY PROFILES
9.1. Elekta AB
9.2. Varian Medical Systems Company
9.3. Huiheng Medical, Inc.
9.4. Nordion Inc.
9.5. ET Medical Group
9.6. American Shared Hospital Services
9.7. Methodist Le Bonheur Healthcare
9.8. Cyber Medical Corporation Limited
9.9. Masep Infini Global Inc.
9.10. Zhuhai Hokai Medical Instruments Co., Ltd
9.11. American Radiosurgery Inc.
9.12. GE Healthcare
9.13. Philips Healthcare
9.14. Nucletron B.V
9.15. Hitachi America Limited
CHAPTER 10 GLOBAL GAMMA KNIFE MARKET - COMPETITIVE LANDSCAPE
10.1. Market Share Analysis
10.2. Strategies adopted by top companies
10.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 11 MARKET INSIGHTS
11.1. Industry Experts Insights
11.2. Analysts Opinions
11.3. Investment Opportunities
CHAPTER 12 APPENDIX
12.1. List of Tables
12.2. List of Figures
